LOS ANGELES, July 26, 2017 -- Ducommun Incorporated (NYSE:DCO) (“Ducommun” or the “Company”) today announced that management will participate in the following events for institutional investors during August, 2017:
Aug. 8: Jefferies Industrials Conference -- New York
Aug. 9: Canaccord Genuity Growth Conference -- Boston
Additional information will be posted on the Company’s website when available, including a copy of the presentation material. Institutional investors are welcome to contact the conference hosts to arrange one-on-one meetings with management.
About Ducommun Incorporated
Ducommun Incorporated delivers value-added, innovative manufacturing solutions to customers in the aerospace, defense and industrial markets. Founded in 1849, the company specializes in two core areas – Electronic Systems and Structural Systems – to produce complex products and components for commercial aircraft platforms, mission-critical military and space programs, and sophisticated industrial applications. For more information, visit www.ducommun.com.
CONTACTS: Douglas L. Groves, Vice President, Chief Financial Officer and Treasurer, 310.513.7200 Chris Witty, Investor Relations, 646.438.9385, [email protected]


Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Italy Fines Apple €98.6 Million Over App Store Dominance
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 



